Home > Income Statement > ORCHID PHARMA

ORCHID PHARMA
Consolidated Net Profit

    Back to Income Statement
ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Consolidated Net Profit ₹46 Cr₹-1.95 Cr₹-117 Cr₹-131 Cr₹70 Cr

What is the latest Consolidated Net Profit of ORCHID PHARMA ?

The latest Consolidated Net Profit ratio of ORCHID PHARMA is ₹46 Cr based on Mar2023 Consolidated results.
Year Consolidated Net Profit
Mar2023₹46 Cr
Mar2022₹-1.95 Cr
Mar2021₹-117 Cr
Mar2020₹-131 Cr
Mar2019₹70 Cr

How is Consolidated Net Profit of ORCHID PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2023 ₹46 Cr
Positive
Mar2022 ₹-1.95 Cr
Negative
Mar2021 ₹-117 Cr
Negative
Mar2020 ₹-131 Cr
Negative
Mar2019 ₹70 Cr -

Compare Consolidated Net Profit of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹5,378.3 Cr 1.4% 2.7% 175.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹364,315.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹114,614.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹105,233.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,900.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹99,426.0 Cr 2.2% -4.6% 86.6% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

1.4%

2.7%

175.1%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses